###### What this paper adds

-   Occupational exposure to grain dust may induce respiratory symptoms in grain handlers, but the dose--response patterns between grain dust exposure and inflammatory response or changes in respiratory function are not consistent between studies. This may be due to differential effects of individual grain dust components, such as mycotoxins, tannins, lectins, endotoxins, fungal spores and β-1,3-glucans, and differences in grain dust composition.

-   This is the first study in the grain and animal feed industry that has investigated the cross-shift respiratory response to exposure for several individual bioaerosol components of the grain dust.

-   Bioaerosol exposure did not lead to cross-shift lung function decline, but several microbial components were associated with nose congestion and self-reporting of symptoms in a complex manner.

-   Exposure to fungal spores and grain dust showed stronger associations with respiratory effects and fatigue than endotoxin exposure.

-   The strong associations with grain dust suggest that there are other components in grain and feed dust than the ones studied that induce respiratory effects and that remain to identify.

Introduction {#s1}
============

Grain dust exposure may induce respiratory symptoms in grain handlers, and measures for reducing the dust exposure have constantly attention in the grain industry. Employees at grain elevators and compound feed mills may be exposed to large amounts of grain dust,[@R1] frequently leading to symptoms from the airways and pulmonary functional changes such as asthma.[@R2] Acute and short-term effects, such as cross-shift lung function decline and toxic pneumonitis, have been observed during a workday,[@R3] and long-term exposure may lead to permanently decreased lung function,[@R7] although results are not always consistent.[@R10] [@R11]

The pathological response to grain dust exposure suggests inflammatory and allergic pathways, although exact mechanisms are under debate. The cell wall component of Gram-negative bacteria, endotoxin, has potential to exert several of the observed health effects caused by grain dust exposure,[@R12] and many studies from the grain industry include endotoxin measurements. On the basis of in vitro studies, animal experiments and epidemiological studies, endotoxin has been proposed as a target for measurements of occupational health hazards related to grain dust exposure.[@R13] However, grain dust also contains several other components, such as mycotoxins, tannins, lectins, lymphocyte mitogens and β-1,3-d-glucans, that may induce immunological, allergic or toxic responses, and interact with the effects of endotoxin.[@R12]

The dose--response patterns between grain dust exposure and inflammatory response or changes in respiratory function are contradictory between studies, possibly due to a differential effect of the individual grain dust components. Furthermore, the microbial composition of the dust will vary between crop types, years/weather conditions, geographic regions, companies and job groups.[@R14] This exposure variability may dilute and even bias exposure--response patterns, and should therefore be considered. Few exposure studies in the grain and animal feed industry have included microbial components, and studies of lung function have been conducted without exposure measurements. Only few exposure--response studies have assessed exposure simultaneously with health examinations. To the best of our knowledge, no study has reported exposure--response associations of other exposure components than grain dust and endotoxins. Thus, information on exposure--response associations with other bioaerosol components is needed to understand health effects after grain dust exposure.

Effects of grain dust exposure on nose congestion by the use of acoustic rhinometry (AR) have, to the best of our knowledge, not been studied before. AR provides objective measurements of the cross-sectional area and volume of the nasal cavity, which may reveal inflammatory responses reflected as swelling of the nose mucosa.[@R15]

In the present study, we therefore aimed to investigate the cross-shift respiratory response of grain dust exposure, and their associations with individual bioaerosol components of the dust. Cross-shift lung function, nasal congestion and symptoms were recorded on the same day as full-shift exposure to inhalable grain dust, endotoxin, bacteria, fungal spores and β-1,3-glucans were assessed.

Materials and methods {#s2}
=====================

Company and job description {#s2a}
---------------------------

Twenty companies of grain elevators and compound feed mills in the Norwegian grain industry geographically distributed throughout 20 municipalities in 9 counties in central and south-eastern Norway were included in this study. Recruitment and description of companies and work tasks is previously published.[@R14]

Study population {#s2b}
----------------

The study population comprised all employees working day shifts; altogether, 68 grain dust exposed workers and 38 assumed unexposed administrative workers as referents. Two workers assigned to the reference group were excluded because of health reasons they had been replaced from exposed jobs to office work, leaving 36 referents. The exposed workers included 28 workers in the grain elevator department, 17 workers in the compound feed mill department, 6 workers in grain elevator and compound feed mill departments and 5 in transport workers. Characteristics of the study population are given in [table 1](#OEMED2015103438TB1){ref-type="table"}. All participants gave their written informed consent on participation in the study. All, but one, of the workers who received the written information agreed to participate. The one who denied participated in the exposure measurements only. The Regional Ethical Committee of South-East Norway and the Norwegian Data Inspectorate approved the study.

###### 

Characteristics of the study population of grain and animal feed industry workers in Norway

                                     Exposed workers (n=68)   Referents (n=36)
  ---------------------------------- ------------------------ ------------------
  Age (year)\*                       41 (16--61)              46 (21--60)
  Height (cm)\*                      179 (162--196)           176 (156--191)
  Weight (kg)\*                      90 (63--123)             83 (55--109)
  Body mass index (kg/m^2^)\*        28 (21--38)              27 (21--38)
  Never-smoker (%)†                  43                       44
  Current smoker (%)†                27                       17
  Ex-smoker (%)†                     31                       39
  Male/female (%)                    94/6                     83/17
  Atopy‡ (%)†                        22                       23
  Physician-diagnosed asthma§        3 (4)                    2 (6)
  Farm childhood (%)†¶               35                       42
  Farm or animals at home (%)†       16                       28
  RPE use (%)†                       16                       0
  FVC (L)\*\*                        5.1 (3.3--8.4)           4.9 (3.3--7.1)
  FVC% pred\*\*                      96 (66--133)             100 (80--122)
  FEV~1~ (L)\*\*                     4.0 (2.7--6.6)           3.7 (1.7--5.4)
  FEV~1~% pred\*\*                   92 (68--127)             93 (51--120)
  FEV~1~/FVC%\*\*                    78 (68--90)              76 (48--89)
  D~L,CO~ (adj) (mmol/min/kPa)\*\*   9.7 (6.3--14.6)          8.8 (3.3--12.6)
  D~L,CO~ % pred\*\*                 86 (32--149)             85 (58--127)
  D-factor\*\*                       0.6 (0.1--1.8)           0.5 (0.1--1.2)

\*AM (minimum--maximum).

†Prevalence.

‡Positive serum reaction towards inhalation panel.

§Self-reported, expressed as n (%).

¶Included one exposed worker that moved to a farm in his youth.

\*\*Lung function at baseline is expressed as AM (minimum--maximum) of actual values and mean per cent of predicted values according to age, height and weight, whereas the nose congestion factor is expressed as AM (minimum--maximum) of a relative value. AM, arithmetic mean; CO, carbon monoxide; D~L,CO~ (adj), CO diffusion capacity of the lung adjusted for the haemoglobulin concentration; D-factor, decongestion factor of the nose; FEV~1~, forced expired volume in the first second; FVC, forced vital capacity; RPE, respiratory protective equipment.

Study design {#s2c}
------------

The field team rigged the equipment at the work site and informed the participating workers on a Monday, and performed exposure measurements and health examinations on a Tuesday. For two companies, exposure measurements and health examinations were performed on a Wednesday. The employees were examined before work (baseline) and after work in a cross-shift design. The examinations included spirometry, gas diffusion tests and AR. The employees were asked to abstain from smoking at least 1 hour before the health examinations. Blood samples were collected after shift for atopy testing and haemoglobin measurements. After work, the employees filled in a questionnaire reporting possible work-related health complaints that day or last week. Thirteen referents and 25 exposed workers were examined over, respectively, 3 and 5 months in the winter, whereas 23 referents and 43 exposed workers were examined over, respectively, 3 and 5 months in the autumn of 2008.

Aerosol exposure measurements and analyses {#s2d}
------------------------------------------

Fifty-six full-shift personal inhalable samples were collected with PAS-6 personal inhalable samplers[@R16] and portable pumps (PS101; National Institute of Occupational Health, Oslo, Norway) for 6--8 hours with a flow rate of 2 L/min. Samples were analysed for grain dust, endotoxins, bacteria, fungal spores and β-1,3-glucans as previously described.[@R1] In brief, dust was weighed, bacteria were stained with acridine orange and counted by epifluorescence microscopy, fungal spores were counted by scanning electron microscopy, endotoxins were analysed by Limulus amoebocyte lysate assay and β-1,3-glucans were analysed by enzyme immunoassay. The job groups and exposure variability have been described previously.[@R1] [@R14]

Questionnaire {#s2e}
-------------

After work shift, the participants filled out a questionnaire based on the ATS recommended respiratory disease questionnaire for epidemiological research[@R17] that included questions on respiratory protective equipment (RPE) use, smoking habits, work history, symptoms of the airways, eyes, skin and gastrointestinal and systemic symptoms experienced during or after work on the day of the examinations. A member of the research team was available for questions from the participants.

Spirometry {#s2f}
----------

After demonstration of the procedure, the spirometry tests were performed with a Jaeger Master screen PFT spirometer (Erich Jaeger GmbH & Co. KG, Würtzburg, Germany) according to the ATS/ERS 2005 criteria with the person sitting and breathing through the mouth piece using a nose clip.[@R18] The spirometer was calibrated daily with a 3 L syringe. The best of any three efforts, regardless of curve, of the forced vital capacity (FVC) and the forced expired volume in the first second (FEV~1~) were used in the analyses. Results of five and six workers before and after shift, respectively, were excluded due to technical reasons. Ninety-five of the 104 workers had acceptable tests before and after shift (91%). FEV~1~/FVC and the percentage of the predicted values for FEV~1~ (FEV~1~% predicted) and FVC (FVC% predicted) were calculated using reference values for a normal population from central Norway.[@R19] Lung function at baseline is expressed as arithmetic mean (AM) (minimum--maximum) of actual values in L, and mean per cent of predicted values according to age, height and weight. Cross-shift changes in lung function are expressed in mL.

Gas diffusion tests {#s2g}
-------------------

The transfer factor for pulmonary carbon monoxide (CO) uptake was measured by single-breath CO diffusion (Jaeger Master Screen PFT, Erich Jaeger GmbH & Co. KG) according to the ATS/ERS 2005 criteria.[@R20] Tests of seven workers before and after shift were excluded due to technical reasons. Ninety workers had acceptable tests before and after shift (87%). The CO diffusion capacity of the lung (D~L,CO~) was adjusted for the concentration of haemoglobulin[@R21] and expressed as mmol/min/kPa. Reference values of the European Coal and Steel Community were used.[@R22] The mean of two D~L,CO~ tests was used in the analyses. The alveolar volume was estimated by using the helium dilution method.

Acoustic rhinometry {#s2h}
-------------------

The nasal cavity dimensions were measured by AR (Rhin2100, Rhino Metrics AS, Lynge, Denmark) with the worker in a seated position, using a hand-held sound wave tube and an anatomical nasal adapter. The mean of three independent measurements with a coefficient of variation \<5% was used for calculations. The total nasal volume and cross-sectional areas were calculated as the sum of both nasal cavities, in order to minimise bias from the nasal cycle. The smallest total cross-sectional area and the total volume between 0--20 mm (anterior; 1) and 20--50 mm (interior; 2) from the nostrils were called TMCA1 and TMCA2, and TVOL1 and TVOL2, respectively. Measurements were performed in the morning before work, after work and 15 min after decongestion with three sprays in each nostril of 1 mg/mL xylometazoline (Otrivin, Novartis Consumer Health, Norway) in order to measure basal dimensions. The degree of mucosal swelling was estimated by the decongestion factor (D-factor) computed as follows:[@R23]

A decongestion factor between 0.2 and 0.4 is regarded normal, 0.4--0.7 indicates a moderate swelling and above 0.7 is regarded severe. A complete set of tests were obtained for 97 workers (93%).

Blood samples {#s2i}
-------------

Blood for haemoglobulin analysis was collected in vacutainers containing EDTA, whereas that for atopy testing was collected in vacutainers without additives. The blood samples were left at room temperature for 30--90 min. Serum was isolated from the blood samples in tubes without additives by 10 min centrifugation at 3500 rpm followed by careful pipetting of serum into new tubes. The serum and the EDTA--blood samples were sent directly to a commercial routine laboratory for analysis. Atopy was defined by the presence of specific serum immunoglobulin E antibodies towards one or more allergens in a panel of typical outdoor airway allergens (birch, timothy, mugwort, *Alternaria tenious* and *Cladosporium herbarum*) determined by Phadiatop screening (Fürst Laboratories, Oslo, Norway).

Statistical analysis {#s2j}
--------------------

Observations of workers not using RPE on the day of investigation were selected (n=92). Differences in symptom prevalence between exposed workers and referents were tested by Pearsons χ^2^ test, and a p value of ≤0.05 was considered statistically significant. Exposure differences between job groups were tested by comparing geometric means (GM) in independent sample t tests. Associations between exposure and cross-shift respiratory changes or symptoms were investigated by using individual bioaerosol exposure values. The exposure values were used categorised at three levels and as continuous variables after log~10~-transformation. Associations with cross-shift changes in lung function or nose congestion were investigated using univariate general linear models with the health parameter as independent, linear exposure variables as dependent covariates and categorical exposure variables as fixed factors. Associations with self-reported symptoms were investigated by logistic regression models. Before logistic regression analyses, all nose symptoms, all eye symptoms, cough+cough with phlegm and all pulmonary symptoms, respectively, were grouped. Confounding effects of age, gender smoking, atopy, farm childhood and contact with farm and pet animals were tested and included in the models when the effect was significant, that is, at a p value of below 0.05 and when changing the β coefficient \>20%.

Results {#s3}
=======

Bioaerosol exposure {#s3a}
-------------------

The GM and SD (geometric standard deviation (GSD)) of dust exposure of all workers was 1.0 mg/m^3^ (2.9). The highest exposure was observed in compound feed mills (GM 1.6 mg/m^3^, GSD 4.0, [table 2](#OEMED2015103438TB2){ref-type="table"}).

###### 

Aerosol exposure of grain and animal feed industry workers in Norway not using respiratory protective equipment

  Aerosol exposure              All job groups   Grain elevator   Compound feed mill   Grain elevator and feed mill   Grain transport
  ----------------------------- ---------------- ---------------- -------------------- ------------------------------ -----------------
  N                             56               28               17                   6                              5
  Grain dust (mg/m^3^)                                                                                                
   GM (GSD)                     1.0 (2.9)        0.9 (2.5)^a^     1.6 (4.0)^abc^       0.5 (1.8)^c^                   0.5 (2.0)^b^
   25th centile                 0.5              0.6              0.6                  0.3                            0.3
   75th centile                 2.0              1.4              4.4                  0.9                            0.9
   Minimum--maximum             0.09--14         0.1--7.0         0.09--14             0.2--1.0                       0.3--1.5
  Endotoxin (EU/m^3^)                                                                                                 
   GM (GSD)                     444 (4.8)        852 (3.9)^ab^    348 (3.4)^a^         107 (5.0)^b^                   146 (7.6)
   25th centile                 194              395              229                  18                             48
   75th centile                 1306             1700             766                  428                            670
   Minimum--maximum             15--10 940       15--10 940       26--2700             17--530                        41--5320
  Bacteria (×10^4^/m^3^)                                                                                              
   GM (GSD)                     17 (5.9)         25 (6.8)^a^      18 (3.3)^b^          2 (5.5)^abc^                   30 (2.5)^c^
   25th centile                 6.5              13               7                    0.3                            16
   75th centile                 55               96               33                   10                             58
   Minimum--maximum             0.3--240         0.3--230         1--240               0.3--15                        11--130
  Fungal spores (×10^4^/m^3^)                                                                                         
   GM (GSD)                     4 (3.3)          4 (3.7)          3 (3.1)              3 (2.9)                        3 (2.3)
   25th centile                 1.4              1.3              1.5                  1.3                            1.4
   75th centile                 8                21               4                    5.4                            6.5
   Minimum--maximum             1.0--50          1.1--48          1.1--50              1.3--20                        1.0--7.8
  β-1,3-Glucans (µg/m^3^)                                                                                             
   GM (GSD)                     6 (4.6)          11 (3.9)^a^      5 (4.1)^b^           1 (2.5)^ab^                    2 (6.0)
   25th centile                 2.3              4                2                    0.6                            0.6
   75th centile                 19               23               15                   3.2                            12
   Minimum--maximum             0.3--151         0.3--151         0.4--42              0.4--3                         0.6--40

GMs with identical letters are significantly different (p≤0.05).

GM, geometric means.

The GM (GSD) concentration of endotoxin was 444 (4.8) EU/m^3^, β-1,3-glucans 6 (4.6) μg/m^3^, bacteria 17×10^4^/m^3^ (5.9) and fungal spores 4×10^4^/m^3^ (3.3). The highest concentrations of all components were in the grain elevator department, except bacterial exposure, which was highest among transport workers (30×10^4^/m^3^ (2.5), [table 2](#OEMED2015103438TB2){ref-type="table"}). Endotoxin and β-1,3-glucan exposure levels were strongly correlated (Pearson correlation coefficient r~P~=0.93), whereas moderate correlations were observed between β-1,3-glucan and dust, between β-1,3-glucan and fungal spores and between endotoxin and grain dust exposure levels (r~P~=0.59--0.66). Endotoxin, bacteria and β-1,3-glucan levels were 3.5--4 times higher for workers using RPE compared with those who did not (p≤0.02 for all), whereas the exposure level for grain dust and fungal spores was similar (not shown).

Self-reported symptoms {#s3b}
----------------------

Exposed workers reported health complaints after work shift more frequently than referents ([table 3](#OEMED2015103438TB3){ref-type="table"}). The prevalence of fever attack (p=0.04), cough (p=0.03), wheezing (p=0.04) and eye itch/sting (p=0.04) was significantly more often reported by exposed workers than that by referents. Only exposed workers reported fever attacks, wheezing and hand itch/sting. Nearly all symptoms were reported by workers not using RPE (not shown). Workers without RPE were selected for further analysis of exposure--response associations in order to avoid overestimation of exposure levels. One exposed worker who had not denoted RPE usage was excluded.

###### 

Prevalence of self-reported acute symptoms in grain and animal feed industry workers in Norway\*

  Symptoms                        Exposed (n=56)   Referents (n=36)   p Value, χ^2^†
  ------------------------------- ---------------- ------------------ ----------------
  Nausea and/or vomit             1 (2)            2 (6)              0.32
  Diarrhoea                       2 (4)            0                  0.25
  Headache                        17 (30)          8 (22)             0.39
  Fatigue                         17 (30)          9 (25)             0.58
  Fever attack                    6 (11)           0                  **0.04**
  Muscular pain                   15 (27)          9 (25)             0.85
  Influenza/cold                  12 (21)          9 (25)             0.69
  Sore throat                     6 (11)           3 (8)              0.71
  Cough                           19 (34)          5 (14)             **0.03**
  Cough with phlegm               11 (20)          2 (6)              0.06
  Cough±phlegm                    20 (22)          6 (17)             **0.05**
  Tight chest                     3 (5)            4 (11)             0.32
  Wheezing                        6 (11)           0                  **0.04**
  Dyspnoea                        7 (13)           3 (8)              0.51
  Wheezing/tight chest/dyspnoea   10 (18)          6 (17)             0.59
  Nose itch/sting                 6 (11)           2 (6)              0.38
  Runny nose                      16 (29)          8 (22)             0.50
  Σ Nose symptoms                 19 (34)          9 (10)             0.43
  Eye itch/sting                  12 (21)          2 (6)              **0.04**
  Runny eyes                      6 (11)           1 (3)              0.16
  Σ Eye symptoms                  13 (23)          2 (6)              **0.03**
  Hand itch/sting                 2 (4)            0                  0.25
  Skin rash                       4 (7)            1 (3)              0.37
  Σ Skins symptoms                5 (9)            1 (3)              0.24

Bold values indicate p≤0.05.

\*n (%) of the study population without respiratory protective equipment.

†p Value calculated between exposed workers and referents.

Individuals exposed to grain dust above 1.3 mg/m^3^ reported significantly more cough with or without phlegm (OR 5.5), wheezing/tight chest/dyspnoea (OR 4.0) and eye symptoms (OR 7.3) than the referents ([table 4](#OEMED2015103438TB4){ref-type="table"}). Cough and cough with phlegm was reported more often among workers exposed to endotoxin above 1200 EU/m^3^ (OR 5.7), fungal spores above 5.5×10^4^/m^3^ (OR 5.0) and β-1,3-glucans above 19 μg/m^3^ (OR 9.0), compared with referents. Eye symptoms were also reported more often in workers exposed to endotoxin levels above 360 EU/m^3^ (OR 6.4, p≤0.05), β-1,3-glucan exposure above 3.7 μg/m^3^ (OR 6.4, p≤0.05) and fungal spore exposure between 1.6×10^4^/m^3^ and 5.4×10^4^/m^3^ (OR 6.1), but not significantly in the highest fungal exposure category (OR 3.9).

###### 

Odds ratios of self-reported acute symptoms by categorical and linear bioaerosol exposure among grain and animal feed industry workers in Norway

                             Fatigue    Cough±phlegm     Wheeze/tight chest/dyspnoea   Nose symptoms     Eye symptoms                                                       
  -------------------------- ---------- ---------------- ----------------------------- ----------------- -------------- --------------- --------- --------------- --------- ---------------
  Grain dust (mg/m^3^)                                                                                                                                                      
   0 (referents)             1                           1                                               1                              1                         1         
   0.09--0.6                 1.3        0.3 to 4.5       1.1\*                         0.2 to 5.3        --             --              0.4       0.08 to 2.1     3.6       0.5 to 24
   0.61--1.3                 1.1        0.3 to 3.8       3.0\*                         0.8 to 11         0.6†           0.1 to 3.4      2.7       0.8 to 8.7      4.5       0.7 to 28
   1.31--14                  1.6        0.5 to 5.3       5.5\*                         1.5 to 20         4.0†           1.1 to 15       2.0       0.6 to 6.5      7.3       1.3 to 41
   per 10-fold increase‡     1.7§       0.5 to 5.8       3.6                           1.0 to 13         26             3.2 to 213      2.5       0.7 to 8.8      2.0       0.5 to 7.8
  Endotoxin (EU/m^3^)                                                                                                                                                       
   0 (referents)             1                           1                                               1                              1                         1         
   15--350                   1.1        0.3 to 3.8       1.8                           0.5 to 6.9        0.7¶           0.1 to 4.0      0.8       0.2 to 3.0      3.2       0.5 to 21
   360--1000                 0.7        0.2 to 2.5       2.3                           0.7 to 8.2        0.5¶           0.09 to 2.8     1.7       0.5 to 5.4      **6.4**   **1.2 to 35**
   1200--11 000              3.4        1.0 to 12        **5.7**                       **1.5 to 21.8**   4.0¶           1.0 to 16       2.6       0.7 to 9.3      **6.2**   **1.0 to 38**
   per 10-fold increase‡     1.8§       0.7 to 4.4       1.7                           0.7 to 4.1        **3.8**        **1.0 to 14**   1.4       0.6 to 3.4      1.4       0.5 to 3.5
  Bacteria (\#/m^3^)                                                                                                                                                        
   0 (referents)             1                           1                                               1                              1                         1         
   0.28×10^4^--14.99×10^4^   1.6        0.5 to 5.3       **5.0**                       **1.4 to 17**     1.7            0.4 to 6.4      **3.7**   **1.2 to 12**   **7.3**   **1.3 to 41**
   15×10^4^--47×10^4^        1.4        0.4 to 4.5       1.5                           0.4 to 5.5        0.5            0.09 to 2.7     0.5       0.1 to 2.0      3.8       0.6 to 23
   58×10^4^--240×10^4^       0.8        0.2 to 3.6       2.8                           0.7 to 11         1.4            0.3 to 6.4      1.7       0.4 to 6.3      4.6       0.7 to 31
   per 10-fold increase‡     0.8§       0.4 to 1.6       0.7                           0.3 to 1.4        0.7            0.3 to 1.6      0.6       0.3 to 1.3      1.0       0.5 to 2.3
  Fungal spores (\#/m^3^)                                                                                                                                                   
   0 (referents)             1                           1                                               1                              1                         1         
   1×10^4^--1.5×10^4^        0.7        0.2 to 2.7       1.6                           0.4 to 5.9        --             --              0.5       0.1 to 2.1      5.3       0.9 to 30
   1.6×10^4^--5.4×10^4^      1.1        0.3 to 3.8       2.9                           0.8 to 11         1.8            0.5 to 6.9      2.2       0.7 to 7.1      **6.1**   **1.1 to 35**
   5.5×10^4^--50×10^4^       3.0        0.9 to 10        **5.0**                       **1.3 to 19**     2.3            0.6 to 9.0      3.0       0.9 to 10       3.9       0.6 to 26
   per 10-fold increase‡     **3.4**§   **1.1 to 10**    **3.2**                       **1.1 to 9.4**    **3.7**        **1.0 to 13**   **4.4**   **1.4 to 14**   1.1       0.3 to 3.6
  β-1,3-Glucans (µg/m^3^)                                                                                                                                                   
   0 (referents)             1                           1                                               1                              1                         1         
   0.30--3.60                0.8        0.2 to 2.8       1.7                           0.4 to 6.3        0.6            0.1 to 3.1      1.0       0.3 to 3.5      3.0       0.5 to 20
   3.70--18.9                0.9        0.3 to 3.1       1.9                           0.5 to 6.8        0.8            0.2--3.5        1.4       0.4 to 4.5      **6.4**   **1.2 to 35**
   19.0--150                 **2.6**    **1.0 to 6.9**   **9.0**                       **2.2 to 37**     2.8            0.7 to 11       3.0       0.8 to 11       **6.8**   **1.1 to 43**
   per 10-fold increase‡     **1.5**§   **1.0 to 2.3**   2.1                           0.9 to 5.0        **3.5**        **1.0 to 12**   1.4       0.6 to 3.4      1.2       0.7 to 3.0

Bold values indicate p\<0.05.

---too few samples in this category.

Associations are expressed as OR with 95% CIs when compared to referents (=OR 1). Workers without respiratory protective equipment (RPE), n=92.

\*Adjusted for gender.

†Adjusted for gender and age.

‡Exposed workers only, n=56.

§OR for a 10-fold increase in exposure level

¶Adjusted for age.

Additionally, workers grouped in the highest exposure category of endotoxin, fungal spores and β-1,3-glucans reported more fatigue than referents (OR 3.0--3.5, [table 4](#OEMED2015103438TB4){ref-type="table"}), although only the association with β-1,3-glucans was significantly different from the referents. Linear exposure--response associations between reported symptoms and some log~10~-transformed bioaerosol concentrations among exposed workers were observed ([table 4](#OEMED2015103438TB4){ref-type="table"}). In particular, fungal spore exposure was related to increased reporting of fatigue, cough with and without phlegm, wheezing/tight chest/dyspnoea and nose symptoms in a dose-dependent manner. Cough with and without phlegm was linearly related with log~10~ grain dust and log~10~ fungal spores, with similar strength (OR 3.6 and OR 3.2, respectively). Wheezing/tight chest/dyspnoea was linearly related to grain dust exposure, fungal spores, β-1,3-glucans and endotoxin, although grain dust was most important (OR 26). Fatigue was linearly related to fungal spores and β-1,3-glucans. To disentangle which component was most important, we adjusted the effect of one significant component for another pairwise in the regression models. This showed that grain dust and fungal spores were associated with cough and cough with phlegm with similar strength (OR 2.5 and 2.3, respectively, p\<0.2), fungal spores and glucan exposure were associated with fatigue with similar strength (OR 2.3 and 1.7, respectively, p\<0.3), but dust exposure was the single most important component for wheeze/chest tightness/dyspnoea.

Lung function {#s3c}
-------------

At baseline, the lung function as per cent of predicted showed no significant differences between exposed workers and referents ([table 1](#OEMED2015103438TB1){ref-type="table"}). The AM FVC% of predicted and the FEV~1~% of predicted were above 90% for all groups, except the FEV~1~% for smokers (87%). The AM FEV~1~/FVC% was between 76% and 78% for all workers. The CO diffusion capacity was above 80% for all worker groups, except for smokers (77%), atopics (79%) and operators working in grain elevators and animal feed mills (79%).

The cross-shift lung function changes showed no consistent associations with any of the aerosol components ([table 5](#OEMED2015103438TB5){ref-type="table"}).

###### 

Cross-shift changes in lung function and nose congestion by exposure category among grain and animal feed industry workers in Norway\*

  Exposure                      ΔFVC (mL)             ΔFEV1 (mL)            ΔD~L,CO~ (mmol/min/Pa)   AR ΔM1 (cm^2^)                       AR ΔV1 (cm^3^)                       AR ΔM2 (cm^2^)           AR ΔV2 (cm^3^)
  ----------------------------- --------------------- --------------------- ------------------------ ------------------------------------ ------------------------------------ ------------------------ -----------------------
  Grain dust (mg/m^3^)                                                                                                                                                                                  
   0 (referents)                0                     0                     0                        0                                    0                                    0                        0
   0.09--0.6                    67 (−60 to 194)       57 (−46 to 161)       153 (−238 to 544)        −0.08 (−0.19 to 0.04)                −0.08 (−0.31 to 0.14)                0.03 (−0.08 to 0.14)     0.06 (−0.77 to 0.89)
   0.61--1.3                    65 (−50 to 181)       −27 (−121 to 67)      −87 (−440 to 265)        −**0.15 (**−**0.26 to** −**0.05)**   −**0.23 (**−**0.43 to** −**0.02)**   −0.005 (−0.11 to 0.10)   0.30 (−0.46 to 1.1)
   1.31--14                     29 (−84 to 142)       17 (−76 to 109)       −64 (−410 to 281)        −**0.12 (**−**0.22 to** −**0.02)**   −0.16 (−0.36 to 0.05)                −0.03 (−0.13 to 0.07)    0.006 (−0.74 to 0.76)
  Endotoxin (EU/m^3^)                                                                                                                                                                                   
   0 (referents)                0                     0                     0                        0                                    0                                    0                        0
   15--350                      46 (−72 to 165)       11 (−86 to 108)       235 (−129 to 598)        −**0.18 (**−**0.29 to** −**0.08)**   −**0.28 (**−**0.49 to** −**0.07)**   0.03 (−0.07 to 0.014)    0.40 (−0.39 to 1.19)
   360--1000                    103 (−5 to 211)       61 (−27 to 149)       −147 (−475 to 181)       −0.10 (−0.20 to 0.004)               −0.15 (−0.34 to 0.05)                −0.002 (−0.10 to 0.09)   −0.06 (−0.78 to 0.67)
   1200--11 000                 −19 (−144 to 106)     −62 (−164 to 40)      −95 (−480 to 289)        −0.08 (−0.19 to 0.04)                −0.05 (−0.28 to 0.17)                −0.05 (−0.15 to 0.06)    0.09 (−0.74 to 0.91)
  Bacteria (counts/m^3^)                                                                                                                                                                                
   0 (referents)                0                     0                     0                        0                                    0                                    0                        0
   0.28×10^4^--14.99×10^4^      65 (−47 to 177)       −14 (−101 to 73)      191 (−156 to 537)        −**0.16 (**−**0.26 to** −**0.05)**   −**0.24 (**−**0.45 to** −**0.04)**   0.02 (−0.08 to 0.12)     0.17 (−0.60 to 0.93)
   15×10^4^--47×10^4^           90 (−24 to 204)       **109 (20 to 198)**   −37 (−384 to 310)        −0.09 (−0.19 to 0.02)                −0.14 (−0.34 to 0.06)                −0.008 (−0.11 to 0.09)   0.11 (−0.64 to 0.86)
   58×10^4^--240×10^4^          −15 (−141 to 110)     −78 (−176 to 20)      −240 (−613 to 133)       −0.11 (0.23 to 0.006)                −0.09 (−0.032 to 0.13)               −0.03 (−0.14 to 0.08)    0.09 (−0.74 to 0.92)
  Fungal spores (counts/m^3^)                                                                                                                                                                           
   0 (referents)                0                     0                     0                        0                                    0                                    0                        0
   1×10^4^--1.5×10^4^           18 (−94 to 130)       45 (−49 to 138)       159 (−200 to 518)        −0.10 (−0.20 to 0.01)                −0.15 (−0.36 to 0.06)                0.01 (−0.09 to 0.11)     0.08 (−0.67 to 0.83)
   1.6×10^4^--5.4×10^4^         **143 (29 to 258)**   38 (−57 to 133)       −138 (−497 to 221)       −**0.13 (**−**0.24 to** −**0.02)**   −0.13 (−0.35 to 0−08)                −0.05 (−0.15 to 0.05)    −0.22 (−0.99 to 0.54)
   5.5×10^4^--50×10^4^          −6 (−123 to 111)      −52 (−150 to 45)      −65 (−424 to 293)        −**0.13 (**−**0.24 to** −**0.02)**   −0.21 (−0.43 to 0.006)               0.03 (−0.08 to 0.13)     0.54 (−0.24 to 1.33)
  β-1,3-Glucans (µg/m^3^)                                                                                                                                                                               
   0 (referents)                0                     0                     0                        0                                    0                                    0                        0
   0.30--3.60                   70 (−46 to 186)       30 (−66 to 126)       44 (−318 to 407)         −**0.13 (**−**0.24 to** −**0.02)**   −0.17 (−0.39 to 0.04)                0.08 (−0.02 to 0.18)     0.51 (−0.25 to 1.28)
   3.70--18.8                   86 (−21 to 194)       31 (−59 to 120)       19 (−322 to 360)         −**0.11 (**−**0.22 to** −**0.01)**   −**0.20 (**−**0.40 to** −**0.01)**   −0.08 (−0.17 to 0.009)   −0.26 (−0.97 to 0.45)
   19.0--150                    −29 (−158 to 100)     −139 (−531 to 254)    −104 (−500 to 290)       −0.12 (−0.24 to 0.004)               −0.09 (−0.32 to 0.14)                0.01 (−0.10 to 0.12)     0.24 (−0.60 to 1.08)

Values are presented as coefficients (95% CI). Bold values indicate p≤0.05.

\*Workers without RPE were selected (n=92).

AR, acoustic rhinometry; ΔFEV1, difference in forced expired volume in the first second; ΔFVC, difference in forced vital capacity; ΔD~L,CO~, difference in CO diffusion capacity of the lung; RPE, respiratory protective equipment.

Nose congestion {#s3d}
---------------

All workers had moderate nose congestion, as shown by a rhinometric D-factor of 0.5 for referents and 0.6 for exposed workers ([table 1](#OEMED2015103438TB1){ref-type="table"}).

Significant reductions of the nasal dimensions in the anterior 2 cm of the nasal mucosa were associated with exposure for several aerosol components ([table 5](#OEMED2015103438TB5){ref-type="table"}). However, the dose--response patterns were inconsistent, although a weak trend could be seen for grain dust and fungal spore exposure. No significant association with continuous log-transformed exposure variables was observed (not shown).

Discussion {#s4}
==========

Exposure for several individually measured bioaerosol components in the Norwegian grain industry and health outcomes such as self-reported symptoms, lung function, CO diffusion capacity and nose congestion was studied in a cross-shift design. Bioaersosol exposure during a work shift with handling of grain and compound feed was associated with increased self-reporting of eye and airway symptoms after work shift. Bioaerosol exposure was not associated with cross-shift lung function decline, but several microbial components affected nose congestion. Self-reported airway symptoms were related to microbial components of the grain dust in a complex manner, showing differential associations between individual symptoms and the individual bioaerosol components. This suggests that each component of the grain dust may give differential effect on inhalation, which is in agreement with the a priori hypothesis.

The exposed workers reported more respiratory symptoms than the referents, which could indicate that inhalation of grain dust still might cause health problems in this industry. Symptoms such as fever attacks, fatigue, muscle pain and cough are typical symptoms of toxic pneumonitis,[@R24] and these symptoms were in our study more often reported by exposed workers than by referents. The reporting of cough among exposed workers was more pronounced in this study compared with a cross-sectional study of animal feed workers.[@R10]

Several symptoms were associated with bioaerosol exposure levels, although the mean dust exposure level was relatively low. The lowest observed effect level (LOEL) cross-shift for cough and cough with phlegm, wheezing/tight chest/dyspnoea and eye symptoms was 1.3 mg/m^3^ inhalable grain dust, which is somewhat lower than the 2.1 mg/m^3^ no observed adverse effect level of total dust for respiratory symptoms previously reported by grain handlers.[@R4] The LOEL of 1.6×10^4^/m^3^ fungal spores for eye symptoms was in the same range as previously reported among Norwegian farmers, whereas the LOEL of 5.5×10^4^/m^3^ fungal spores for cough and cough with phlegm in the present study was lower.[@R25] The highest exposure category of endotoxin (1200--11 000 EU/m^3^) and β-1,3-glucan (19--150 µg/m^3^) was associated with cough and cough with phlegm, but the linear dose--response relationship among exposed workers was not statistically significant, indicating that the exposure to endotoxin and glucan may not be as important for the reporting of these symptoms as grain dust and fungal spores. The exposure to GM 0.83 (0.09--15.2) mg/m^3^ of total dust and GM 54.2 (4.4--744) EU/m^3^ of endotoxin has been associated with respiratory symptoms reported by wheat harvest workers.[@R26] In the present study, fatigue, wheezing/tight chest/dyspnoea and nose symptoms reported by exposed workers were associated with fungal spore exposure in a dose-dependent manner. However, the symptom prevalence ratios were not significantly different from the referents, so no LOEL could be identified from the categorical groups of fungal exposure levels. In spite of the high prevalence, eye symptoms were not linearly associated with any of the measured aerosol components. The fact that reported eye symptoms in exposure categories of all aerosol components nevertheless were significantly different from the referents indicates that eye symptoms may occur at low exposure levels. The present study shows LOELs at normal conditions in the grain industry. The bioaerosol exposure can be higher and dominated by different microorganisms when handling problematic materials, as shown in a case study where workers handling problematic grass seeds developed toxic pneumonitis.[@R27] [@R28]

A lung function \<100% of predicted at baseline may indicate a detrimental effect of long-term grain dust exposure, although the cross-shift change in lung function was small and inconsistent within the study population. Cross-shift lung function reductions seemed to be associated with the highest exposure categories of all bioaerosol components, although no linear trends were seen. Our results seem to be in line with the long-term decline in lung function that is commonly observed in studies of grain workers, whereas cross-shift effects are less consistent. Corey *et al*[@R3] found a baseline decline of FVC, FEV~1~, maximal expiratory flow at 50% of FVC (MEF~50~) and maximal respiratory function at 75% of FVC (MEF~75~) from Monday to Friday, but increases in FVC and FEV~1~ cross-shifts and cross-week among grain elevator workers. Smid *et al*[@R10] demonstrated a cross-week FEV~1~ decline, but no cross-shift FEV~1~ decline among animal feed workers. Cross-shift lung function changes have been observed among grain handlers[@R4] and wheat harvest workers.[@R26] Whereas cross-shift change in wheat harvest workers was not consistently related to the dust or endotoxin exposure,[@R26] where decreases in FVC were found among grain handlers significantly correlated with increasing grain dust exposure, and workers exposed to AM 3.3 (SD 7) mg/m[@R3] of total dust had a cross-shift FVC decline of 46 mL.[@R4] In five cross-sectional surveys over a period of 12 years, Chan-Yeung *et al*[@R11] consistently found that grain workers had more respiratory symptoms and lower lung function compared with civic workers, despite a progressive reduction in dust levels in the grain elevators from GM (SD) 10.1 mg/m^3^ (3.3) in 1974 to 1.9 mg/m[@R3] (3.4) in 1988. The latter is similar to the dust level in the present study.

Referents and exposed workers had moderate nose congestion as shown by a D-factor of 0.5 and 0.6, respectively. Exposed workers had cross-shift reduction in area and volume of the anterior part of the nose. This suggests a local inflammation after deposition of grain dust and its contaminants, and is supported by the association between AR nose effects and the highest two exposure categories of grain dust and fungal spores. Similar results have been reported among waste collectors, in which nasal congestion and exposure to fungal spores and β-1,3-glucans correlated with an increased level of inflammatory markers in the nasal lavage.[@R29] All, but the grain elevator workers, showed an opposite response in the interior part of the nose. In the anterior part of the nose, the mucosa extends over a smaller surface area than the interior part. Measurements of mucosal swelling in the anterior part are therefore likely to be more accurate and may better reflect an inflammatory response of dust exposure.

There were no significant difference in lung function between exposed workers and referents. This could be due to reduced acute effects of dust exposure, a kind of tolerance previously shown among pig farmers and grain handlers with long-term exposure of organic dust.[@R3] [@R30] Lung function below 100% of predicted may indicate that a long-term effect of exposure has already reduced the lung function, thus supporting this view. It is also plausible that individuals sensitive to exposure change jobs to avoid hazardous exposure, leaving the ones who cope behind, thus resulting in a selection of healthy worker into exposed jobs. It may furthermore be possible that referents were sporadically exposed, which reduces the exposure contrasts between the groups. Several referents and exposed workers also had a farm or animals at home. There were no dose--response association between exposure and cross-shift lung function changes in spite of relatively high exposure levels. This may be due to a large proportion of large particles in the inhalable fraction, probably being most active in the upper airways, whereas the pulmonary effects are expected to occur from smaller particle sizes in the thoracic and respirable aerosol fraction. Although spores and bacteria are likely to protrude in the thoracic and alveolar region of the lungs, it is possible that they stick to larger fragments or are present as aggregates that deposit higher up in the airways. The associations between aerosol components, and AR nose effects and reported nose symptoms indicate that this was the case. On the other hand, spirometry and gas diffusion tests do not always reflect all processes in the development of airway diseases. Self-reporting of symptoms seemed to be more sensitive, but this may be due to the participants\' greater focus on occupational exposure, resulting in over-reporting of respiratory symptoms.[@R31] Validity and reliability are general problems with questionnaires. However, we believe that specificity problems were limited in this study because the selection of questions was adapted to the study by relating to a priori defined possible effects of the relevant exposure components, and related in time to the workday. The guidance of participants during filling in the questionnaire also reduced possible misunderstandings of the questions. Given that the low lung function among workers is caused by long-term occupational exposure, the increased reporting of symptoms from the airways is in agreement with another study from occupational settings.[@R32] In clinical settings, however, self-reported symptoms seldom correlate with objective measurements of lung function such as FEV~1.~[@R33] [@R34] All of the above will lead to an underestimation of exposure--response relationships in the grain elevator and compound feed mill industry, and should be considered when interpreting the results of this study. On the other hand, the selection of workers without RPE will reduce dilution problems in the exposure--response associations. Multiple testing might have led to spurious significant findings, but the number of positive associations found are greater than expected taking multiple testing into account. Significant associations between symptoms and exposure measurements are more plausible when a linear trend along the exposure categories is shown, such as between several symptoms and spore and dust exposure. The significant associations between exposure and cross-shift lung function increases and AR associations without dose--response trends are more likely to be spurious.

Previous publications from this study showed that although grain dust exposure was low, microbial exposure levels exceeded health-based recommended values[@R1] and exposure levels varied between job groups and tasks.[@R14] The present study shows how bioaerosol components individually and combined affected the respiratory health of workers in grain elevators, compound feed mills and transport in a complex manner. Differential linear associations between individual symptoms and the exposure level of individual bioaerosol components demonstrated this. This suggests that each component of the grain dust may give differential effect on inhalation. Fatigue and nose symptoms were strongest associated with fungal spores; cough and cough with phlegm were associated with grain dust and fungal spores with equal strength. Wheeze/tight chest/dyspnoea was strongest associated with grain dust, indicating that components of the dust not measured are involved. Some candidate effect inducers may be a large number of microbial metabolites previously detected in grain dust.[@R35] It is also likely that some additives of animal feed could have effects.
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